{"id":366329,"date":"2021-05-20T17:36:40","date_gmt":"2021-05-20T21:36:40","guid":{"rendered":"https:\/\/www.ip.gov.py\/ip\/?p=366329"},"modified":"2021-05-20T18:49:24","modified_gmt":"2021-05-20T22:49:24","slug":"taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos","status":"publish","type":"post","link":"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/","title":{"rendered":"Taiw\u00e1n con vacunas en desarrollo avanzado y Paraguay podr\u00eda participar de ensayo cl\u00ednico"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong><em>Asunci\u00f3n, Agencia IP.- <\/em><\/strong>La Rep\u00fablica de China (Taiw\u00e1n) cuenta con cuatro prototipos de vacunas anticovid-19 en desarrollo, de las cuales est\u00e1n m\u00e1s avanzadas y existen tratativas para que Paraguay participe de los ensayos cl\u00ednicos y tenga prioridad para la adquisici\u00f3n.<!--more--><\/p>\n<p style=\"text-align: justify;\">El embajador taiw\u00e1nes en Paraguay, Jos\u00e9 Han, confirm\u00f3 que existe el inter\u00e9s de un laboratorio local para realizar los ensayos cl\u00ednicos dentro de la Fase 3 del desarrollo de vacunas.<\/p>\n<p style=\"text-align: justify;\">Han indic\u00f3 que la propuesta fue planteada por el entonces exministro de Salud, Julio Mazzoleni, y se realizaron los contactos con uno de los laboratorios fabricantes. De participar en los ensayos cl\u00ednicos, el pa\u00eds tendr\u00e1 prioridad en el acceso, dijo en entrevista con el programa Tribuna de Paraguay TV.<\/p>\n<p style=\"text-align: justify;\">El diplom\u00e1tico a\u00f1adi\u00f3 que uno de los laboratorios taiwaneses ya firm\u00f3 un acuerdo de preventa por cerca de 165 millones de dosis con Brasil, Per\u00fa y Ecuador. La expectativa es que para inicios de julio est\u00e9 aprobado el uso de emergencia de las vacunas producidas en Taiw\u00e1n.<\/p>\n<p style=\"text-align: justify;\">Indic\u00f3 tambi\u00e9n que aunque no forme parte de los ensayos cl\u00ednicos, Paraguay ser\u00e1 prioridad y recibir\u00e1 el apoyo del Gobierno taiwan\u00e9s en las negociaciones con los laboratorios privados.<\/p>\n<p style=\"text-align: justify;\">A fines de abril, desde la Facultad de Ciencias M\u00e9dicas de la Universidad Nacional de Asunci\u00f3n (FCE-UNA) <strong><a href=\"https:\/\/www.ip.gov.py\/ip\/paraguay-podria-participar-en-ensayos-clinicos-de-vacuna-taiwanesa-anti-covid-19\/\">informaron<\/a><\/strong> que se remitieron documentaciones a Taiw\u00e1n para llevar a cabo el estudio de la Fase 3, que requiere de la aplicaci\u00f3n en un variado n\u00famero de personas en busca de posibles efectos secundarios.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Asunci\u00f3n, Agencia IP.- La Rep\u00fablica de China (Taiw\u00e1n) cuenta con cuatro prototipos de vacunas anticovid-19 en desarrollo, de las cuales est\u00e1n m\u00e1s avanzadas y existen tratativas para que Paraguay participe de los ensayos cl\u00ednicos y tenga prioridad para la adquisici\u00f3n.<\/p>\n","protected":false},"author":22,"featured_media":365182,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[2984,2,6],"tags":[63,2639,5845],"class_list":["post-366329","post","type-post","status-publish","format-standard","has-post-thumbnail","category-covid-19","category-destacado","category-politica","tag-taiwan","tag-tribuna-tv","tag-vacuna-contra-covid-19"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Taiw\u00e1n con vacunas en desarrollo avanzado y Paraguay podr\u00eda participar de ensayo cl\u00ednico - .::Agencia IP::.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Taiw\u00e1n con vacunas en desarrollo avanzado y Paraguay podr\u00eda participar de ensayo cl\u00ednico - .::Agencia IP::.\" \/>\n<meta property=\"og:description\" content=\"Asunci\u00f3n, Agencia IP.- La Rep\u00fablica de China (Taiw\u00e1n) cuenta con cuatro prototipos de vacunas anticovid-19 en desarrollo, de las cuales est\u00e1n m\u00e1s avanzadas y existen tratativas para que Paraguay participe de los ensayos cl\u00ednicos y tenga prioridad para la adquisici\u00f3n.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/\" \/>\n<meta property=\"og:site_name\" content=\".::Agencia IP::.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPParaguay\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-20T21:36:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-20T22:49:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/05\/vacunaci\u00f3n-4.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"1244\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Alberto C\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:site\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alberto C\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/05\\\/20\\\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/05\\\/20\\\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\\\/\"},\"author\":{\"name\":\"Alberto C\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/369fedd28420fad35e23b10a9df16fb8\"},\"headline\":\"Taiw\u00e1n con vacunas en desarrollo avanzado y Paraguay podr\u00eda participar de ensayo cl\u00ednico\",\"datePublished\":\"2021-05-20T21:36:40+00:00\",\"dateModified\":\"2021-05-20T22:49:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/05\\\/20\\\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\\\/\"},\"wordCount\":282,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/05\\\/20\\\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/vacunaci\u00f3n-4.jpg\",\"keywords\":[\"Taiw\u00e1n\",\"Tribuna TV\",\"vacuna contra covid-19\"],\"articleSection\":[\"COVID-19\",\"Destacado\",\"Pol\u00edtica\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/05\\\/20\\\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/05\\\/20\\\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\\\/\",\"name\":\"Taiw\u00e1n con vacunas en desarrollo avanzado y Paraguay podr\u00eda participar de ensayo cl\u00ednico - .::Agencia IP::.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/05\\\/20\\\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/05\\\/20\\\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/vacunaci\u00f3n-4.jpg\",\"datePublished\":\"2021-05-20T21:36:40+00:00\",\"dateModified\":\"2021-05-20T22:49:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/05\\\/20\\\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/05\\\/20\\\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/05\\\/20\\\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/vacunaci\u00f3n-4.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/vacunaci\u00f3n-4.jpg\",\"width\":1280,\"height\":1244,\"caption\":\"Vacunaci\u00f3n en los centro masivo habilitado en la Secretar\u00eda de Deportes. Foto Oficina de la Primera Dama.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/05\\\/20\\\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Taiw\u00e1n con vacunas en desarrollo avanzado y Paraguay podr\u00eda participar de ensayo cl\u00ednico\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"name\":\".::Agencia IP::.\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\",\"name\":\"Agencia IP\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"width\":150,\"height\":150,\"caption\":\"Agencia IP\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPParaguay\\\/\",\"https:\\\/\\\/x.com\\\/IPParaguay\",\"https:\\\/\\\/www.instagram.com\\\/IPParaguay\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/369fedd28420fad35e23b10a9df16fb8\",\"name\":\"Alberto C\",\"sameAs\":[\"https:\\\/\\\/www.ip.gov.py\"],\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/author\\\/acelma\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Taiw\u00e1n con vacunas en desarrollo avanzado y Paraguay podr\u00eda participar de ensayo cl\u00ednico - .::Agencia IP::.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/","og_locale":"es_ES","og_type":"article","og_title":"Taiw\u00e1n con vacunas en desarrollo avanzado y Paraguay podr\u00eda participar de ensayo cl\u00ednico - .::Agencia IP::.","og_description":"Asunci\u00f3n, Agencia IP.- La Rep\u00fablica de China (Taiw\u00e1n) cuenta con cuatro prototipos de vacunas anticovid-19 en desarrollo, de las cuales est\u00e1n m\u00e1s avanzadas y existen tratativas para que Paraguay participe de los ensayos cl\u00ednicos y tenga prioridad para la adquisici\u00f3n.","og_url":"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/","og_site_name":".::Agencia IP::.","article_publisher":"https:\/\/www.facebook.com\/IPParaguay\/","article_published_time":"2021-05-20T21:36:40+00:00","article_modified_time":"2021-05-20T22:49:24+00:00","og_image":[{"width":1280,"height":1244,"url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/05\/vacunaci\u00f3n-4.jpg","type":"image\/jpeg"}],"author":"Alberto C","twitter_card":"summary_large_image","twitter_creator":"@IPParaguay","twitter_site":"@IPParaguay","twitter_misc":{"Escrito por":"Alberto C","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/#article","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/"},"author":{"name":"Alberto C","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/369fedd28420fad35e23b10a9df16fb8"},"headline":"Taiw\u00e1n con vacunas en desarrollo avanzado y Paraguay podr\u00eda participar de ensayo cl\u00ednico","datePublished":"2021-05-20T21:36:40+00:00","dateModified":"2021-05-20T22:49:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/"},"wordCount":282,"publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/05\/vacunaci\u00f3n-4.jpg","keywords":["Taiw\u00e1n","Tribuna TV","vacuna contra covid-19"],"articleSection":["COVID-19","Destacado","Pol\u00edtica"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/","url":"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/","name":"Taiw\u00e1n con vacunas en desarrollo avanzado y Paraguay podr\u00eda participar de ensayo cl\u00ednico - .::Agencia IP::.","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/#primaryimage"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/05\/vacunaci\u00f3n-4.jpg","datePublished":"2021-05-20T21:36:40+00:00","dateModified":"2021-05-20T22:49:24+00:00","breadcrumb":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/#primaryimage","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/05\/vacunaci\u00f3n-4.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/05\/vacunaci\u00f3n-4.jpg","width":1280,"height":1244,"caption":"Vacunaci\u00f3n en los centro masivo habilitado en la Secretar\u00eda de Deportes. Foto Oficina de la Primera Dama."},{"@type":"BreadcrumbList","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/05\/20\/taiwan-con-vacunas-en-desarrollo-avanzado-y-paraguay-podria-participar-de-ensayos-clinicos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ip.gov.py\/ip\/"},{"@type":"ListItem","position":2,"name":"Taiw\u00e1n con vacunas en desarrollo avanzado y Paraguay podr\u00eda participar de ensayo cl\u00ednico"}]},{"@type":"WebSite","@id":"https:\/\/www.ip.gov.py\/ip\/#website","url":"https:\/\/www.ip.gov.py\/ip\/","name":".::Agencia IP::.","description":"","publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ip.gov.py\/ip\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ip.gov.py\/ip\/#organization","name":"Agencia IP","url":"https:\/\/www.ip.gov.py\/ip\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","width":150,"height":150,"caption":"Agencia IP"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPParaguay\/","https:\/\/x.com\/IPParaguay","https:\/\/www.instagram.com\/IPParaguay"]},{"@type":"Person","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/369fedd28420fad35e23b10a9df16fb8","name":"Alberto C","sameAs":["https:\/\/www.ip.gov.py"],"url":"https:\/\/www.ip.gov.py\/ip\/author\/acelma\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/366329","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/comments?post=366329"}],"version-history":[{"count":0,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/366329\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media\/365182"}],"wp:attachment":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media?parent=366329"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/categories?post=366329"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/tags?post=366329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}